Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001209191-14-060754
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-10-01 21:03:03
Reporting Period:
2014-09-29
Filing Date:
2014-10-01
Accepted Time:
2014-10-01 21:03:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1157602 Vitae Pharmaceuticals Inc VTAE Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1135669 Prospect Venture Partners Ii Lp C/o Prospect Venture Partners
435 Tasso Street, Suite 200
Palo Alto CA 94301
No No Yes No
1162055 Prospect Venture Partners Lp C/o Prospect Venture Partners
435 Tasso Street, Suite 200
Palo Alto CA
No No Yes No
1162056 Prospect Management Co Llc C/o Prospect Venture Partners
435 Tasso Street, Suite 200
Palo Alto CA 94301
No No Yes No
1162057 Prospect Management Co Ii Llc C/o Prospect Venture Partners
435 Tasso Street, Suite 200
Palo Alto CA 94301
No No Yes No
1162059 C Russell Hirsch C/o Prospect Venture Partners
435 Tasso Street, Suite 200
Palo Alto CA 94301
No No Yes No
1162060 David Schnell C/o Prospect Venture Partners
435 Tasso Street, Suite 200
Palo Alto CA 94301
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-09-29 261,977 $0.00 293,498 No 4 C Indirect See Footnote
Common Stock Acquisiton 2014-09-29 261,977 $0.00 293,498 No 4 C Indirect See Footnote
Common Stock Acquisiton 2014-09-29 102,301 $0.00 395,799 No 4 C Indirect See Footnote
Common Stock Acquisiton 2014-09-29 1,530,269 $0.00 1,823,767 No 4 C Indirect See Footnote
Common Stock Acquisiton 2014-09-29 76,949 $0.00 1,900,716 No 4 C Indirect See Footnote
Common Stock Acquisiton 2014-09-29 671,807 $8.00 2,572,523 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 P Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A-2 Preferred Stock Disposition 2014-09-29 173,912 $0.00 261,977 $0.00
Common Stock Series A-2 Preferred Stock Disposition 2014-09-29 173,912 $0.00 261,977 $0.00
Common Stock Series B Preferred Stock Disposition 2014-09-29 102,301 $0.00 102,301 $0.00
Common Stock Series B Preferred Stock Disposition 2014-09-29 1,530,269 $0.00 1,530,269 $0.00
Common Stock Series C Preferred Stock Disposition 2014-09-29 76,949 $0.00 76,949 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 31,520 Indirect See Footnote
Common Stock 31,520 Indirect See Footnote
Footnotes
  1. Each outstanding share of Series A-2 Preferred Stock automatically converted on a 1:1.50638118 basis into the Issuer's common stock, immediately prior to the Issuer's initial public offering, for no additional consideration.
  2. The reportable securities are owned by Prospect Venture Partners, L.P. ("PVP"). Prospect Management Co., L.L.C. ("PMC") is the general partner of PVP. David Schnell ("Schnell") is the managing member of PMC. Each of PMC and Schnell disclaim beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of its pecuniary interest therein.
  3. The reportable securities are owned by Prospect Venture Partners II, L.P. ("PVP II"). Prospect Management Co. II, L.L.C. ("PMC II") is the general partner of PVP II. Russell Hirsch ("Hirsch") and Schnell are the managing members of PMC II. Each of PMC II, Hirsch and Schnell disclaim beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of its pecuniary interest therein.
  4. Each share of Series B Preferred Stock and Series C Preferred Stock automatically converted on a 1:1 basis into the Issuer's common stock, immediately prior to the Issuer's initial public offering, for no additional consideration.
  5. The reportable securities are owned by PVP, as Nominee. PMC is the general partner of PVP. Schnell is the managing member of PMC. Each of PMC and Schnell disclaim beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of its pecuniary interest therein.
  6. The reportable securities are owned by PVP II, as Nominee. PMC II is the general partner of PVP II. Hirsch and Schnell are the managing members of PMC II. Each of PMC II, Hirsch and Schnell disclaim beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of its pecuniary interest therein.